Literature DB >> 14614603

Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis.

Masanori Abe1, Fazle Akbar, Aki Hasebe, Norio Horiike, Morikazu Onji.   

Abstract

BACKGROUND: Glycyrrhizin (GL), an aqueous extract of licorice root, is known to have various immune-modulating and biological response-modifier activities. GL is used in patients with hepatitis to reduce the activity of liver inflammation; however, the mechanism underlying the anti-inflammatory activity of GL is poorly understood. As antigen-presenting dendritic cells (DC) in the tissue play a major role in the regulation of the inflammatory mucosal milieu during tissue inflammation, we studied whether the function of liver DC was altered by GL therapy in a murine model of concanavalin-A (con A)-induced hepatitis.
METHODS: Liver DC were propagated from control mice or mice with Con-A-induced hepatitis, and the effect of GL on liver DC was evaluated in vivo and in vitro.
RESULTS: The levels of interleukin (IL)-10 produced by liver DC were significantly lower in mice with Con-A-induced hepatitis compared with control mice. However, treatment with GL caused increased production of IL-10 in mice with Con A-induced hepatitis. The increased production of IL-10 by mice with Con A-induced hepatitis was also confirmed in vitro by culturing liver DC with GL.
CONCLUSIONS: This study indicates that increased production of IL-10 by liver DC due to GL administration may be involved in downregulation of the levels of liver inflammation in mice with Con A-induced hepatitis. Glycyrrhizin (GL), an aqueous extract of licorice root, is known to have various immune-modulating and biological response-modifier activities. GL is used in patients with hepatitis to reduce the activity of liver inflammation; however, the mechanism underlying the anti-inflammatory activity of GL is poorly understood. As antigen-presenting dendritic cells (DC) in the tissue play a major role in the regulation of the inflammatory mucosal milieu during tissue inflammation, we studied whether the function of liver DC was altered by GL therapy in a murine model of concanavalin-A (Con A)-induced hepatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614603     DOI: 10.1007/s00535-003-1179-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Suppressive role of hepatic dendritic cells in concanavalin A-induced hepatitis.

Authors:  C Tomiyama; H Watanabe; Y Izutsu; M Watanabe; T Abo
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  18β-glycyrrhetinic acid inhibits periodontitis via glucocorticoid-independent nuclear factor-κB inactivation in interleukin-10-deficient mice.

Authors:  H Sasaki; N Suzuki; E Alshwaimi; Y Xu; R Battaglino; L Morse; P Stashenko
Journal:  J Periodontal Res       Date:  2010-12       Impact factor: 4.419

Review 3.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

4.  Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

Authors:  Eduardo Vilar Gomez; Yadina Martinez Perez; Hector Vega Sanchez; Gretel Riveron Forment; Enrique Arus Soler; Luis Calzadilla Bertot; Ali Yasells Garcia; Maria del Rosario Abreu Vazquez; Licet Gonzalez Fabian
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

5.  Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice.

Authors:  Noriko Tsuruoka; Kazuki Abe; Kenjirou Wake; Masaru Takata; Akira Hatta; Tositugu Sato; Hideo Inoue
Journal:  Inflamm Res       Date:  2009-03-31       Impact factor: 4.575

6.  18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells.

Authors:  Ying Qu; Wei-Hua Chen; Lei Zong; Ming-Yi Xu; Lun-Gen Lu
Journal:  Med Sci Monit       Date:  2012-01

7.  Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study.

Authors:  Nilesh Chande; Maggie Laidlaw; Paul Adams; Paul Marotta
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.487

8.  Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial.

Authors:  Eduardo Vilar Gomez; Yoan Sanchez Rodriguez; Ana Torres Gonzalez; Luis Calzadilla Bertot; Enrique Arus Soler; Yadina Martinez Perez; Ali Yasells Garcia; Maria Del Rosario Abreu Vazquez
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

Review 9.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.

Authors:  Camila Dos Santos Leite; Gabriel Alves Bonafé; Juliana Carvalho Santos; Carlos Augusto Real Martinez; Manoela Marques Ortega; Marcelo Lima Ribeiro
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 10.  Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.

Authors:  Florent Duval; Jorge E Moreno-Cuevas; María Teresa González-Garza; Carmen Maldonado-Bernal; Delia Elva Cruz-Vega
Journal:  Int J Inflam       Date:  2015-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.